Últimas noticias sobre MINISO Group Holding (NYSE:MNSO) Bolsa

MINISO Group Holding

MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

Pre-Market Outlook

Markets

Movers

ACON

AEON

BCTX

CPHC

EKSO

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

KITT

LDTC

MBOT

MEGL

MNSO

NSTS

SPPL

WFCF

Explora los mayores movimientos en el premercado con ganancias superiores al 100% y pérdidas significativas antes de la apertura.

Acciones de Smart Share Global se disparan un 44%; 20 acciones que se mueven en el premercado

Earnings

News

Trading Ideas

DELL

LULU

ULTA

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este viernes: JKS, LULU, MNSO, ULTA y DELL.

5 acciones en el foco este viernes: JKS, LULU, MNSO, ULTA y DELL

MINISO Group Holding Limited American Depositary Shares, each representing four Ordinary Shares

MINISO Group Holding Ltd

Wells Fargo analyst Colin Langan maintains Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) with a Underweight and lowers the price target from $9 to $8.

Price Target

Analyst Ratings

Wells Fargo Maintains Underweight on Ford Motor, Lowers Price Target to $8

WIIM

Haemonetics shares are trading lower after the company reported Q3 financial results and missed its revenue estimate.

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) with a Equal-Weight and lowers the price target from $74 to $70.

CNMD

Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $70

Wedbush analyst Robert Driscoll maintains Kura Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>) with a Outperform and raises the price target from $34 to $36.

KURA

Wedbush Maintains Outperform on Kura Oncology, Raises Price Target to $36

Semiconductor equipment and material supplier Entegris&nbsp;Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) reported its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43522215/entegris-reports-results-for-fourth-quarter-of-2024" rel="noreferrer noopener">fiscal fourth-quarter 2024</a> earnings Thursday before the market opened.
What To Know: The company reported adjusted EPS of 84 cents, topping <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of 78 cents</a>. Entegris reported sales of $849.84 million, marking a 5% growth year-over-year and quashing the analyst consensus estimate of $823.12 million.
Segments: Materials Solutions revenue declined 1.1% to $361.08 million. Advanced Purity Solutions revenue grew by 9.2% to $491.19 million.
However, the company&#8217;s adjusted net sales, excluding the impact of divestitures, increased by 11% Y/Y.
Materials Solutions segment profit grew 45% to $771.22 million. Purity Solutions segment profit increased 14.4% to $134.97 million.
Entegris also reported other key financial indicators, including an adjusted EBITDA margin of 29.2% (versus 26.0% Y/Y), an adjusted operating margin of 23.5% (versus 20.7% Y/Y), and an adjusted gross margin of 45.6% (versus 42.4% Y/Y).
CEO Bertrand Loy noted that Entegris continued to outperform the market, with EBITDA growth twice its sales growth rate.
Loy flagged limited visibility outside of advanced logic and AI-driven applications as it enters 2025. The company will continue to fund critical investments that improve its long-term competitiveness and position it for the industry upturn. Loy found the company well-positioned for the upcoming technology node transitions, likely generating incremental content per wafer opportunities.
Outlook: The company issued guidance for the fiscal first quarter of 2025. Entegris anticipates sales between $775 million-$805 million versus <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst estimates of $796.26 million</a>. Furthermore, the company expects adjusted EPS from 64 cents to 71 cents below analyst estimates of 74 cents.
Entegris stock lost over 12% in the last 12 months as multiple Wall Street firms <a target="_blank" href="https://www.benzinga.com/quote/ENTG/analyst-ratings" rel="noreferrer noopener">slashed their price targets</a> after a dismal <a target="_blank" href="https://www.benzinga.com/news/24/11/41717366/whats-going-on-with-entegris-shares-monday" rel="noreferrer noopener">third-quarter print</a>. Loy told customers with significant exposure to AI applications performed well, but the rest of the industry continues to be challenged.
Price Action: ENTG stock is up 5.38% at $109.49 at the last check in Thursday.
Read next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43528027/hersheys-stock-pops-as-q4-earnings-beat-expectationsbut-cocoa-prices-loom-over-2025-outlook" target="_blank" rel="noreferrer noopener">Hershey&#8217;s Stock Pops As Q4 Earnings Beat Expectations—But Cocoa Prices Loom Over 2025 Outlook</a></li>
</ul>
Photo via Shutterstock

Guidance

ENTG

Entegris Q4 Earnings: Revenue And Profit Beat, Warns of 2025 Uncertainty Beyond AI Growth

ASTS

AST SpaceMobile shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a price target of $30.

Wells Fargo analyst Vik Chopra maintains Envista Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVST#NYSE">NVST</a>) with a Equal-Weight and raises the price target from $20 to $21.

NVST

Wells Fargo Maintains Equal-Weight on Envista Holdings, Raises Price Target to $21

IDCC

InterDigital shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 adjusted EPS guidance above estimates. The company also announced an increase in its quarterly dividend from $0.45 per share to $0.60.

Biotech

General

Lilly Exec Says U.S. Prescriptions Of Alzheimer's Drug Kisunla Steadily Increasing Since Launch

Wells Fargo analyst Michael Brown maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Equal-Weight and raises the price target from $77 to $83.

Wells Fargo Maintains Equal-Weight on Moelis, Raises Price Target to $83

Linde PLC&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>) shares are trading lower after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/ac43522457/linde-reports-full-year-and-fourth-quarter-2024-results-earnings-release-tables-attached" rel="noreferrer noopener">reported&nbsp;fourth-quarter&nbsp;FY24 results</a>.
<ul>
<li>Sales rose&nbsp;5%&nbsp;Y/Y to&nbsp;$8.28&nbsp;billion, underlying sales up&nbsp;2%&nbsp;Y/Y, missing the consensus of&nbsp;$8.39 billion.&nbsp;</li>
<li>Americas sales rose&nbsp;1%&nbsp;Y/Y to&nbsp;$3.61&nbsp;billion, APAC (Asia Pacific) sales increased&nbsp;2%&nbsp;Y/Y to&nbsp;$1.67&nbsp;billion&nbsp;and, EMEA (Europe, Middle East &amp; Africa) sales was down&nbsp;2%&nbsp;Y/Y to&nbsp;$2.06&nbsp;billion&nbsp;in the quarter.</li>
<li>Linde Engineering sales stood at $628 million, down 5% Y/Y, in the quarter.</li>
<li>Adjusted operating profit increased&nbsp;9%&nbsp;Y/Y to&nbsp;$2.48&nbsp;billion, with margin expanding 250&nbsp;basis points Y/Y to&nbsp;29.9%, led by increased price and continued productivity initiatives across all segments.</li>
<li>Adjusted EPS was&nbsp;$3.97,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beating the consensus of&nbsp;$3.93</a>.</li>
<li>As of FY24, Linde's total project backlog stood at&nbsp;$10.4 billion. The company returned&nbsp;$7.1&nbsp;billion&nbsp;to shareholders through dividends and share repurchases in the year.</li>
<li>Operating cash flow stood at&nbsp;$9.4&nbsp;billion, with capital expenditures of&nbsp;$4.5&nbsp;billion&nbsp;in the year.</li>
</ul>
Outlook: For the&nbsp;first-quarter&nbsp;of FY25, the company expects adjusted EPS of&nbsp;$3.85&nbsp;–&nbsp;$3.95&nbsp;(up&nbsp;7%-9%&nbsp;ex. FX),&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">vs. consensus of&nbsp;$4.02</a>.
Linde projects FY25 adjusted EPS of&nbsp;$16.15-$16.55&nbsp;(up 8%-11% Y/Y ex. FX) vs. street view of&nbsp;$16.83.
The company expects FY25 capital expenditures of $5 billion-$5.5 billion to support operating and growth requirements, which includes the contractual sale of gas backlog.
CEO Sanjiv Lamba praised the company&#8217;s 25.9% ROC, 29.5% operating margin and EPS growth of 10% excluding currency. 
&#8220;The results were delivered despite the challenging environment, reflecting the resiliency of our model and the exceptional execution by our employees,&#8221; Lamba said. 
Linde also signed its largest ever product supply agreement with a customer, supporting a $10 billion project backlog which Lamba expects will contribute to earnings growth &#8220;for years to come.&#8221;
Investors can gain exposure to the stock via iShares U.S. Basic Materials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYM#NYSE">IYM</a>) and Materials Select Sector SPDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>).
Price Action: LIN shares are down 2.36% at $443 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42319010/aramco-linde-schlumberger-form-alliance-for-one-of-the-worlds-largest-ccs-hubs" target="_blank" rel="noreferrer noopener">Aramco, Linde, Schlumberger Form Alliance For Carbon Capture And Storage Hub</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

iShares Trust Dow Jones US Basic Materials Sector Index Fund

Linde Q4: Revenue Misses, EPS Tops, Shares Dip on Soft Guidance

Deep-pocketed investors have adopted a bearish approach towards Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LRCX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Lam Research. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 62% bearish. Among these notable options, 3 are puts, totaling $252,236, and 5 are calls, amounting to $306,221.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $110.0 for Lam Research during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lam Research's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lam Research's whale trades within a strike price range from $35.0 to $110.0 in the last 30 days. 
<h3>Lam Research Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738854943_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.6</td>
<td>$3.4</td>
<td>$3.6</td>
<td>$106.00</td>
<td>$126.3K</td>
<td>92</td>
<td align="right">351</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.95</td>
<td>$3.75</td>
<td>$3.95</td>
<td>$68.00</td>
<td>$105.4K</td>
<td>251</td>
<td align="right">267</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.15</td>
<td>$4.3</td>
<td>$64.00</td>
<td>$89.8K</td>
<td>302</td>
<td align="right">209</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.0</td>
<td>$4.8</td>
<td>$5.0</td>
<td>$110.00</td>
<td>$62.5K</td>
<td>1.3K</td>
<td align="right">125</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.25</td>
<td>$3.05</td>
<td>$3.25</td>
<td>$108.00</td>
<td>$59.4K</td>
<td>36</td>
<td align="right">183</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
Having examined the options trading patterns of Lam Research, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Lam Research</h3>
<ul>
<li>Currently trading with a volume of 1,095,617, the LRCX's price is down by -0.05%, now at $81.9. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 76 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lam Research with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

LRCX

Spotlight on Lam Research: Analyzing the Surge in Options Activity

Financial giants have made a conspicuous bullish move on AstraZeneca. Our analysis of options history for AstraZeneca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) revealed 11 unusual trades.
Delving into the details, we found 63% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $320,360, and 5 were calls, valued at $216,678.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $60.0 to $95.0 for AstraZeneca over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of AstraZeneca stands at 1822.71, with a total volume reaching 912.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AstraZeneca, situated within the strike price corridor from $60.0 to $95.0, throughout the last 30 days.
<h3>AstraZeneca Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738854938_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AZN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$21.55</td>
<td>$21.2</td>
<td>$21.55</td>
<td>$95.00</td>
<td>$161.6K</td>
<td>1</td>
<td align="right">75</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$20.85</td>
<td>$19.15</td>
<td>$19.34</td>
<td>$60.00</td>
<td>$56.0K</td>
<td>117</td>
<td align="right">50</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$7.2</td>
<td>$6.85</td>
<td>$7.0</td>
<td>$67.50</td>
<td>$51.8K</td>
<td>1.8K</td>
<td align="right">96</td>
</tr>
<tr>
<td>AZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.75</td>
<td>$4.7</td>
<td>$4.75</td>
<td>$70.00</td>
<td>$42.7K</td>
<td>2.8K</td>
<td align="right">12</td>
</tr>
<tr>
<td>AZN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.7</td>
<td>$21.65</td>
<td>$21.7</td>
<td>$95.00</td>
<td>$41.2K</td>
<td>1</td>
<td align="right">75</td>
</tr>
</tbody>
</table>

<h3>About AstraZeneca</h3>
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
<h3>Present Market Standing of AstraZeneca</h3>
<ul>
<li>Trading volume stands at 1,628,717, with AZN's price up by 4.08%, positioned at $73.83.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AstraZeneca, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

AstraZeneca Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OKLO, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 21 uncommon options trades for Oklo.
This isn't normal.
The overall sentiment of these big-money traders is split between 57% bullish and 33%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $144,435, and 17 are calls, for a total amount of $2,731,918.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $70.0 for Oklo over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Oklo's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Oklo's significant trades, within a strike price range of $20.0 to $70.0, over the past month.
<h3>Oklo 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738854932_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$18.05</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$30.00</td>
<td>$731.5K</td>
<td>2.0K</td>
<td align="right">500</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$11.45</td>
<td>$10.2</td>
<td>$10.9</td>
<td>$65.00</td>
<td>$436.0K</td>
<td>2.5K</td>
<td align="right">400</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$25.45</td>
<td>$24.8</td>
<td>$25.3</td>
<td>$24.00</td>
<td>$303.6K</td>
<td>1.4K</td>
<td align="right">220</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$25.65</td>
<td>$24.45</td>
<td>$25.37</td>
<td>$22.50</td>
<td>$253.2K</td>
<td>4.5K</td>
<td align="right">110</td>
</tr>
<tr>
<td>OKLO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$25.75</td>
<td>$24.65</td>
<td>$25.0</td>
<td>$24.00</td>
<td>$250.0K</td>
<td>1.4K</td>
<td align="right">320</td>
</tr>
</tbody>
</table>

<h3>About Oklo</h3>
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
Following our analysis of the options activities associated with Oklo, we pivot to a closer look at the company's own performance.
<h3>Where Is Oklo Standing Right Now?</h3>
<ul>
<li>With a trading volume of 7,335,368, the price of OKLO is down by -6.34%, reaching $47.3.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 12 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Oklo</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $40.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Craig-Hallum has revised its rating downward to Buy, adjusting the price target to $44. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Oklo, which currently sits at a price target of $31. 
&#x2A; Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Oklo, targeting a price of $45. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Oklo with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

OKLO

Oklo's Options: A Look at What the Big Money is Thinking

Fox News viewers got an unexpectedly blunt look at the real impact of President Donald Trump's latest tariffs. During an <a href="https://x.com/VABVOX/status/1886152648203669848">interview</a> with Rep. Nancy Mace (R-SC) earlier this week,&nbsp; anchor Jon Scott pointed out that the tariffs could affect &#8220;virtually every sector of the American economy,&#8221; as a long list of goods scrolled across the screen.&nbsp;
The list included everyday items like maple syrup, ground beef, fruits and vegetables, shoes, lumber and steel, as well as cars from BMW, Audi, Nissan, Mazda and Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>).
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-nancy-pelosi">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000</a></li>
</ul>
The U.S. threatened to impose 25% duties on imports from Mexico and Canada, with a 10% tariff on Chinese goods. Although Trump ran on a platform of lowering energy and grocery costs, analysts argue the tariffs will actually raise prices. Trump acknowledged that the action might cause &#8220;a little pain,&#8221; but he maintained that it was &#8220;worth the price.&#8221;
The tariffs have already triggered global pushback. Canada and Mexico <a href="https://www.benzinga.com/markets/25/02/43423087/canada-retaliates-against-trumps-tariffs-with-countermeasures-25-tariffs-on-107-billion-of-us-made-goods">responded with their own retaliatory tariffs</a>, while <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43454424/china-strikes-back-new-tariffs-up-to-15-on-certain-us-imports-in-retaliation-for-trumps-10-levy-on-chinese-goods">China has imposed up to 15% duties</a> on U.S. coal, liquefied natural gas, crude oil, and farm machinery. Beijing has also taken its case to the World Trade Organization and launched an antitrust investigation into Google. Meanwhile, the European Union has warned it will &#8220;respond firmly&#8221; if <a href="https://www.benzinga.com/markets/25/02/43420164/trump-may-enforce-new-tariffs-on-key-sectors-starting-saturday-chips-steel-among-potential-targets">Trump extends tariffs to its member nations</a> which seems likely.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
After consulting with their leaders, Trump decided to <a href="https://www.benzinga.com/government/regulations/25/02/43440692/us-mexico-agrees-on-one-month-tariffs-pause-stocks-rebound-peso-rallies">postpone tariffs</a> on Canada and Mexico for a month, despite reservations. Mexico pledged to send 10,000 troops to its northern border to curb the flow of fentanyl and illegal migration, while Canada reaffirmed its commitment to border security. However, the economic uncertainty remains, with Trump suggesting more tariffs could follow.
Concern has also been voiced by some Republicans in Congress. Sen. Mitch McConnell (R-KY) criticized the action and warned that it would be expensive for consumers. While applauding the halt on Mexico, Sen. Chuck Grassley (R-IA) encouraged Trump to waive tariffs on potash, a necessary commodity for fertilizer.
See Also: According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions">Join the first company to bring blockchain payments to Salesforce early with just $100.</a>
Markets reacted sharply, with the Dow dropping nearly 600 points before recovering slightly on news of the tariff pause. The Wall Street Journal <a href="https://www.benzinga.com/markets/cannabis/25/02/43476012/trumps-canada-tariffs-bffs-for-decades-what-went-wrong-can-it-really-be-about-fentanyl-unlikely">referred to Trump&#8217;s trade war</a> as &#8220;the dumbest in history,&#8221; and even Fox News&#8217; coverage emphasized the potential economic consequences.&nbsp;
American households are already under stress due to high prices, and the tariffs create even more uncertainty. Businesses and consumers alike are preparing for the impact while discussions continue, despite Trump&#8217;s insistence that they are an essential tool for applying pressure to trading partners.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce">this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</a></li>
</ul>

Fox News Stuns Audience With A Scrolling List Of Goods Facing Tariffs—'Virtually Every Sector Of The American Economy Potentially Targeted'

Wells Fargo analyst Michael Brown maintains T. Rowe Price Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) with a Equal-Weight and lowers the price target from $118 to $116.

TROW

Wells Fargo Maintains Equal-Weight on T. Rowe Price Gr, Lowers Price Target to $116

Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) has outperformed the market over the past 5 years by 25.51% on an annualized basis producing an average annual return of 38.05%. Currently, Natera has a market capitalization of $23.14 billion. 
Buying $100 In NTRA: If an investor had bought $100 of NTRA stock 5 years ago, it would be worth $495.06 today based on a price of $175.25 for NTRA at the time of writing.
<h3>Natera's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738854910_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTRA

$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today

Lilly Exec Says In Q4 Zepbound Became The Market Leader In The Anti-Obesity Market As Measured By New Prescriptions

Eldorado Gold shares are trading lower. The company provided 2025 production guidance and announced a delay for its Skourie project.

Wells Fargo analyst Michael Brown maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $207 to $215.

ARES

Wells Fargo Maintains Overweight on Ares Management, Raises Price Target to $215

MINISO Group Holding ( ($MNSO) ) just unveiled an update. MINISO Group Holding Limited, a global retailer, announced a reduction in its issued shar...

MINISO Group Reduces Issued Shares Through Strategic Repurchase

Miniso (MNSO) is up 7.9%, or $1.99 to $27.20. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....

Miniso rises 7.9%

MINISO Group announces $550M equity-linked securities offering; shares down

Wall Street is confidently higher today, looking to kick of the second week of 2025 with a bang.

Tech, Autos Help Wall Street Charge Higher

In a report released today, Clement Xu from DBS maintained a Buy rating on MINISO Group Holding (MNSO – Research Report), with a price target of $2...

DBS Sticks to Its Buy Rating for MINISO Group Holding (MNSO)

Miniso Seems Poised For Further Upside

The latest announcement is out from MINISO Group Holding ( ($MNSO) ). On January 14, 2025, MINISO Group announced the completion of a US$550 millio...

MINISO Completes $550 Million Equity Offering to Boost Global Market Position

MINISO Group Holding ( ($MNSO) ) has shared an announcement. On January 17, 2025, MINISO Group Holding Limited held an extraordinary general meetin...

MINISO Group Announces Shareholder Approval for Acquisition

Emerging Markets: Navigating Q4 Volatility And Challenges

MINISO Group Holding ( ($MNSO) ) just unveiled an update. MINISO Group Holding Limited submitted a report to the Hong Kong Stock Exchange for Janua...

MINISO Reports Stable Share Capital for January 2025

BDGSF

BIDU

CEGHF

ITUB

MELI

PYCR

SSNLF

Press Releases

MINISO Group Will Report September Quarter 2024 Financial Results on November 29, 2024

Entertainment

Magical Wonders Await: MINISO Launches 800+ Harry Potter Inspired Products Globally

MINISO Announces Extraordinary General Meeting on January 17, 2025

MINISO Group Announces September Quarter and First Nine Months of 2024 Unaudited Financial Results

SHAREHOLDER ALERT: Pomerantz Law Firm Updates Shareholders with Investment Losses in MINISO Regarding Class Action Lawsuit - MNSO

European Debut: MINISO Unveils Its Innovative 'MINISO LAND' - A Pioneering IP-scenerio Retail Concept

Offerings

MINISO Group Announces Offering of US$550 Million Equity Linked Securities

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

MINISO Launches Flagship Store in Thailand, Building Another Landmark in SE Asia

MINISO Group Announces Results of Extraordinary General Meeting

Amazon.com

Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share

Alibaba Gr Hldgs

Baozun

Coupang

Dillard's

1stdibs.com

eBay

Etsy

Global E Online

Groupon

D-Market Electronic Services & Trading - American Depositary Shares

D-MARKET Electronic

Hour Loop

JD.com, Inc. - American Depositary Shares

JD.com

Jumia Technologies AG American Depositary Shares, each representing two Ordinary Shares

Jumia Technologies

Nordstrom

Kohl's

ContextLogic

Macy's

MercadoLibre

Ollie's Bargain Outlet Holdings, Inc. - Common Stock

Ollie's Bargain Outlet

PDD Holdings Inc. - American Depositary Shares

PDD Holdings

Qurate Retail, Inc. - Series A Common Stock

Qurate Retail

Qurate Retail, Inc. - Series B Common Stock

Savers Value Village

Vipshop Holdings Limited American Depositary Shares, each representing two ordinary shares

Comments

MINISO Group Holding

Noticias

Últimas noticias sobre MINISO Group Holding (NYSE:MNSO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL